Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
Supreme Court to keep mulling state PBM dispute as US urges justices to decline case
Last month
Pharma
Eisai, Merck stave off generic competition to blockbuster cancer drug Lenvima
Last month
Pharma
Axsome and Hetero settle patent fight over sleep disorder drug
Last month
Pharma
Sernova chair resigns following insider trading indictment over Novartis-Chinook deal
Last month
People
US warns drugmakers against misrepresenting cost of imported products
Last month
Pharma
Manufacturing
Federal judge extends order blocking RFK Jr. from reorganizing HHS
Last month
FDA+
House passes Trump tax bill with PBM and orphan drug reforms included
Last month
Pharma
Teva, Novartis get fresh warnings from FTC over Orange Book patent listings
Last month
Pharma
Updated: Trump administration reveals 'most favored nation' drug price country targets
Last month
Pharma
HHS can require approval for drugmakers to apply 340B rebate models, court rules
Last month
Pharma
Amarin calls Hikma's drug label arguments 'idiosyncratic,' urges high court to decline case
Last month
Pharma
Regeneron scores $400M+ jury win in Amgen cholesterol drug spat
Last month
Pharma
CRISPR patent spat revived by federal appeals court ruling
Last month
Cell/Gene Tx
HHS focuses on 'transparency' in third-round IRA negotiation guidance
Last month
Pharma
Lack of detail in Trump's drug price plan raises more questions than answers
Last month
Pharma
PBM overhaul and drug price negotiations make the cut in Republicans' tax bill
Last month
Pharma
AstraZeneca loses appeals court fight over IRA drug price negotiations
2 months ago
Pharma
Avadel can pursue label expansion for narcolepsy drug Lumryz after court ruling
2 months ago
Pharma
Compounders just lost their case to put obesity drug tirzepatide back in shortage
2 months ago
Pharma
Health Tech
States sue US over plan for reorganization of federal health agencies
2 months ago
Pharma
Exclusive: SEC expected to drop investigation of Illumina's $8B Grail deal
2 months ago
Deals
Diagnostics
BeiGene scores a win from US Patent Office in spat over Brukinsa
2 months ago
Pharma
Regeneron loses bid to fend off DOJ fight over Eylea Medicare payments
2 months ago
Pharma
AstraZeneca posts another Truqap study fail, says China import tax could triple
2 months ago
China
Pharma
First page
Previous page
1
2
3
4
5
Next page
Last page